The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
The farnesoid X receptor (FXR) is a bile acid-regulated nuclear receptor expressed in enterohepatic tissues. In this study we investigated whether FXR is expressed by cells of innate immunity and regulates inflammation in animal models of colitis. Acute (7 days) and chronic (8 wk) colitis were induced in wild-type and FXR−/− mice by intrarectal administration of trinitrobenzensulfonic acid or by 7-day administration of 5% dextran sulfate in drinking water. The results of this experiment demonstrate that FXR is expressed by and exerts counterregulatory effects on cells of innate immunity. Exposure of LPS-activated macrophages to 6-ethyl chenodeoxycholic acid (6E-CDCA; INT-747) a synthetic FXR ligand, results in a reciprocal regulation of NF-κB dependent-genes (TNF-α, IL-1β, IL-6, COX-1, COX-2, and iNOS) and induction of SHP, a FXR-regulated gene. FXR activation stabilizes the nuclear corepressor NCoR on the NF-κB responsive element on the IL-1β promoter. Colon inflammation in Crohn’s disease patients and in rodent models of colitis is associated with a reduced expression of FXR mRNA. Using two rodent models of colon inflammation, we show that progression of these immune-mediated disorders is exacerbated in FXR−/− mice (p < 0.01). In vivo treatment with INT-747 attenuates organ injury and immune cell activation. FXR activation increased the colon expression of I-BABP, FXR, and SHP while reducing IL-1β, IL-2, IL-6, TNF-α, and IFN-γ mRNA expression and attenuating disease severity. In aggregate, these findings provide evidence that FXR is an essential component of a network of nuclear receptors that regulate intestinal innate immunity and homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FXR is implicated in intestinal immunomodulation and barrier function (Vavassori et al., 2009).”
From Bacteroides dorei BDX-01 alleviates DSS-induced experimental colitis in mice by regulating intestinal bile salt hydrolase activity and the FXR-NLRP3 signaling pathway (2023) · cites this paper as Vavassori et al., 2009
In the citing paper
“An additional benefit of FXR activation in the intestine is based on intestinal immunity modulation and decreased ileal bacterial invasion.[80,81]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [80]
In the citing paper
“treatment with a synthetic agonist of BAR has protective effects in mouse models of colitis, whereas BAR-deficient (Nr1h4−/−) mice exhibit exacerbated pathology (Gadaleta et al., 2011; Vavassori et al., 2009).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Vavassori et al., 2009
Citations
Cites
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
The Immunology of Mucosal Models of Inflammation
Strober, W., Fuss, I. J., & Blumberg, R. S. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064816 · Cited by 1,304
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., & Glass, C. K. (2005) · Nature · doi:10.1038/nature03988 · Cited by 1,254
Cited by
Items 401–500 of 657
Honke, N., Shaabani, N., Hardt, C., Krings, C., Häussinger, D., Lang, P. A., Lang, K. S., & Keitel, V. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000456168 · Cited by 18
The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease
Shen, X. Z., Li, Y., Wang, D., & Sun, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1690279 · Cited by 30
Bai, Y., Zhao, T., Gao, M. M., Zou, Y., & Lei, X. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00264 · Cited by 22
Yao, Y., Zhang, P., Wang, J., Chen, J., Wang, Y., Huang, Y., Zhang, Z., & Xu, F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00122 · Cited by 18
Fuji, H., Miller, G., Nishio, T., Koyama, Y., Lam, K., Zhang, V., Loomba, R. S., Brenner, D. A., & Kisseleva, T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.790032 · Cited by 19
Cipriani, S., Mencarelli, A., Bruno, A. M., Renga, B., Distrutti, E., Santucci, L., Baldelli, F., & Fiorucci, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02128.x · Cited by 21
Self-citationMicrobial bile acid modifications: current understandings, key problems, and future perspectives
Zhang, H., Wen, J., Liu, X., Feng, Y., Liu, X., & Ning, K. (2025) · Science China Life Sciences · doi:10.1007/s11427-025-3019-2 · Cited by 21
Fousekis, F. S., Mpakogiannis, K. C., Lianos, G. D., Antonelli, E., Bassotti, G., & Katsanos, K. H. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217817 · Cited by 23
Obeticholic acid for the treatment of primary biliary cirrhosis
Jones, D. E. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1216784 · Cited by 18
Metabolism of bile acids in the post-prandial state
Fiamoncini, J., Curi, R., & Daniel, H. (2016) · Essays in Biochemistry · doi:10.1042/ebc20160052 · Cited by 19
Mooranian, A., Zamani, N., Takechi, R., Al-Sallami, H. S., Mikov, M., Goločorbin-Kon, S., Kovačević, B., Arfuso, F., & Al‐Salami, H. (2019) · Therapeutic Delivery · doi:10.4155/tde-2019-0052 · Cited by 17
Nijmeijer, R. M., Schaap, F. G., Smits, A. J. J., Kremer, A. E., Akkermans, L. M. A., Kroese, A. B. A., Rijkers, G. T., Schipper, M. E. I., Verheem, A., Wijmenga, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114393 · Cited by 19
New drug therapies for metabolic dysfunction-associated steatohepatitis
Chiang, J. Y. L. (2025) · Liver Research · doi:10.1016/j.livres.2025.01.001 · Cited by 19
Gut-Microbiota-Driven Lipid Metabolism: Mechanisms and Applications in Swine Production
Xiong, S. (2025) · Metabolites · doi:10.3390/metabo15040248 · Cited by 21
Jiao, Y., Ren, J., Xie, S., Yuan, N., Shen, J., Yin, H., Wang, J., Guo, H., Cao, J., Wang, X., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2488105 · Cited by 19
Ma, Y., Yang, H., Wang, X., Huang, Y., Li, Y., & Pan, G. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118968 · Cited by 20
Gastro-intestinal tract: The leading role of mucosal immunity
Steinert, A., Radulovic, K., & Niess, J. H. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14293 · Cited by 21
The Effect of Probiotics on Lipid Metabolism
Zhang, Y., & Zhang, H. (2013) · InTech eBooks · doi:10.5772/51938 · Cited by 21
Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
Torres, J., Palmela, C., de Sena, P. G., Santos, M. P. C., Gouveia, C. F., Oliveira, M. H., Henriques, A. R., Rodrigues, C. M. P., Cravo, M. L., & Borralho, P. (2017) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000481197 · Cited by 16
FXR/TGR5 mediates inflammasome activation and host resistance to bacterial infection
Kang, J., Kim, M., & Yim, M. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101051 · Cited by 24
Mosińska, P., Storr, M., & Fichna, J. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15587866 · Cited by 16
Storti, F. (2008) · Cited by 16
Zhang, Y., Wang, B., Yang, Y., Meng, J., Zhang, M., Li, Y., Dong, B., Zhang, Y., Liu, B., Yang, D. H., et al. (2025) · iMeta · doi:10.1002/imt2.70061 · Cited by 15
Bile acid modulation of host immunity
Anh, N. B., Yang, X., & Hang, H. C. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.70014 · Cited by 17
FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis
Ghimire, J., Iftikhar, R., Penrose, H. M., Snarski, P., Ruiz, E. M., & Savkovic, S. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119730 · Cited by 17
Gut Microbiome and Bile Acid Interactions
Wu, N., Bayatpour, S., Hylemon, P. B., Aseem, S. O., Brindley, P. J., & Zhou, H. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.11.004 · Cited by 17
Xie, S., Guo, C., Chi, Z., Huang, B., Wu, Y., Wang, D., & Xia, D. (2017) · FEBS Letters · doi:10.1002/1873-3468.12782 · Cited by 17
Zhang, Z., Zhou, H., Guan, M., Zhou, X., Liang, X., Lv, Y., Bai, L., Zhang, J., Gong, P., Liu, T., et al. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003013 · Cited by 17
Li, Q., Dai, W., Kong, J., Tian, Y., & Chen, Y. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00782-w · Cited by 15
Supplemental Leuconostoc mesenteroides strain NTM048 attenuates imiquimod‐induced psoriasis in mice
Ogawa, C., Inoüe, R., Yonejima, Y., Hisa, K., Yamamoto, Y., & Suzuki, T. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15161 · Cited by 16
Wu, M., Zuo, S., Maiorano, G., Kosobucki, P., & Stadnicka, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1040434 · Cited by 19
Zhou, S., Li, Y., Hu, L., Qin, W., Cao, Y., Tang, Z., Li, H., Hu, X., Fang, Z., Li, S., et al. (2023) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.12560 · Cited by 14
Xiao, Y., Jia, Y., Liu, W., Niu, C., Mai, Z., Dong, J., Zhang, X.-S., Yuan, Z., Ji, P., Wei, Y., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1399829 · Cited by 14
Cholic Acid Feeding Leads to Increased CYP2D6 Expression in CYP2D6-Humanized Mice
Pan, X., Kent, R., Won, K., & Jeong, H. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074013 · Cited by 16
Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients
Wilson, A. S., Wang, Q., Almousa, A. A., Jansen, L. E., Choi, Y., Schwarz, U. I., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-68686-9 · Cited by 14
Intestinal-pulmonary axis: a ‘Force For Good’ against respiratory viral infections
Zhu, J., Huang, Z., Lin, Y., Zhu, W., Zeng, B., & Tang, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1534241 · Cited by 21
Baldi, S., Turrini, M., Cei, F., Menicatti, M., Bartolucci, G., & Amedei, A. (2026) · BioFactors · doi:10.1002/biof.70078 · Cited by 16
Glaucoma and the Human Microbiome
Chang, C.-C. J., Liu, B., Liebmann, J. M., Cioffi, G. A., & Winn, B. J. (2024) · Journal of Glaucoma · doi:10.1097/ijg.0000000000002448 · Cited by 15
FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammation
O'Guinn, M. L., Handler, D. A., Hsieh, J. J., Mallicote, M. U., Feliciano, K., & Gayer, C. P. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2024 · Cited by 16
Buchynskyi, M., Oksenych, V., Kamyshna, I. I., Vorobets, I., Halabitska, I., & Kamyshnyi, O. (2024) · Viruses · doi:10.3390/v16060985 · Cited by 18
Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development
Sánchez, P. S., Rigual, M. D. M., & Djouder, N. (2021) · Cancers · doi:10.3390/cancers13205045 · Cited by 13
Perrigoue, J., Das, A., & Mora, J. R. (2014) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000360685 · Cited by 14
Ding, M., Fan, J., Wang, W., Wang, H., & Liu, H. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.03.031 · Cited by 14
Patented Farnesoid X receptor modulators: a review (2019 – present)
Gioiello, A., Rosatelli, E., & Cerra, B. (2024) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2024.2314296 · Cited by 14
Chilton, S. (2014) · Journal of Nutrition & Food Sciences · doi:10.4172/2155-9600.1000364 · Cited by 11
Xu, G., Li, Y., Jiang, X., & Chen, H. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25518 · Cited by 12
Activation of farnesoid X receptor attenuates liver injury in systemic lupus erythematosus
Lian, F., Wang, Y., Chen, J., Xu, H., Yang, X., Liang, L., Zhan, Z., Ye, Y., & Chen, M. (2011) · Rheumatology International · doi:10.1007/s00296-011-1874-2 · Cited by 14
Design and synthesis of bile acid derivatives and their activity against colon cancer
Wang, Z., Qiang, X., Peng, Y., Wang, Y., Zhao, Q., & He, D. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00220e · Cited by 11
Canovai, E., Farré, R., Accarie, A., Lauriola, M., Hertogh, G. D., Vanuytsel, T., Pirenne, J., & Ceulemans, L. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914881 · Cited by 13
Hua, R., Qiao, G., Chen, G., Sun, Z., Jia, H., Li, P., Zhang, B., & Qi, F. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s440076 · Cited by 13
Xiong, H., Chen, H., Chen, L., Ouyang, K., Lin, S., & Wang, W. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250078 · Cited by 11
Yin, Y., Feng, W., Chen, X., Chen, J., Wang, G., Xia, L., & Wu, K. (2024) · The Innovation Medicine · doi:10.59717/j.xinn-med.2024.100092 · Cited by 13
Wang, T., Tian, T., Zhu, Z., Fang, S., Zhang, L., Peng, X., Shi, R., Li, Y., Wu, J.-S., & Ma, Y. (2024) · Phytotherapy Research · doi:10.1002/ptr.8326 · Cited by 11
Saccharomyces boulardii Alleviates Colitis by Regulating FXR-NLRP3 Mediated Macrophage Pyroptosis
Yang, L., Li, W., Zhao, Q., Mo, Q., Liu, T., & Cao, H. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s504957 · Cited by 14
Liu, X., Guan, K., Ma, Y., Jiang, L., Li, Q., Liu, Y., Mao, K., & Wang, R. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c12392 · Cited by 17
The effects of taurochenodeoxycholic acid in preventing pulmonary fibrosis in mice.
Zhou, C., Shi, Y., Li, J., Zhang, W., Wang, Y., Liu, Y., & Liu, J. (2013) · PubMed · Cited by 13
From bugs to behavior: targeting the gut-brain interface for addiction therapeutics
Ru, Y., Jia, J., Yang, X., Ba, X., Yan, J., Zhang, H., & Zhang, Y. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2569740 · Cited by 10
The gut-liver axis modulates intestinal immune homeostasis
Gu, Y., & Wu, C. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.12.001 · Cited by 15
Benjaskulluecha, S., Boonmee, A., Haque, M., Wongprom, B., Pattarakankul, T., Pongma, C., Sri-ngern-ngam, K., Keawvilai, P., Sukdee, T., Saechue, B., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108733 · Cited by 11
Sun, S., Zhang, G., Lv, S., & Sun, J. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1407991 · Cited by 11
Harnessing gut microbiota for longevity: Insights into mechanisms and genetic manipulation
Shi, P., Xu, S., Yang, Z., Wang, L., Wu, Y., Li, Y., & Zhu, Z. (2024) · iMetaOmics. · doi:10.1002/imo2.36 · Cited by 11
Yang, L., Zhou, X., Liu, J., Yang, G., Tan, W., Ding, H., Fang, X., Yu, J., Li, W., He, J., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.003 · Cited by 19
Bile Acids in Control of the Gut-Liver-Axis
Hild, B., Heinzow, H. S., Schmidt, H., & Maschmeier, M. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1330-9644 · Cited by 11
Cariello, M., Zerlotin, R., Pasculli, E., Piccinin, E., Peres, C., Porru, E., Roda, A., Gadaleta, R. M., & Moschetta, A. (2022) · Cancers · doi:10.3390/cancers14133081 · Cited by 12
Meshanni, J. A., Lee, J. M., Vayas, K. N., Sun, R., Jiang, C., Guo, G. L., Gow, A. J., Laskin, J. D., & Laskin, D. L. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001557 · Cited by 12
Fiber consumption stimulates the activity of microbial bile salt hydrolases
Gregor, A., Auernigg‐Haselmaier, S., Malleier, M., Bruckberger, S., Séneca, J., Pjevac, P., Pignitter, M., & Duszka, K. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105707 · Cited by 11
Dysregulation of Bile Acids in Patients with NAFLD
Zhang, X., & Deng, R. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81474 · Cited by 17
Zhang, P., Xu, S., Li, N., & Yu, C. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09176-8 · Cited by 11
Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
Nortunen, M., Väkiparta, N., Porvari, K., Saarnio, J., Karttunen, T. J., & Huhta, H. I. (2021) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-021-03066-w · Cited by 9
Advances in understanding the regulatory mechanism of organic solute transporter α-β
Lu, Z.-N., He, H., & Zhang, N. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121109 · Cited by 10
Baumeister, T., Proaño-Vasco, A., Metwaly, A., Kleigrewe, K., Kuznetsov, A., Schömig, L. R., Borgmann, M., Khiat, M., Anand, A., Strangmann, J., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101505 · Cited by 15
How Microbial Food Fermentation Supports a Tolerant Gut
Poppe, J., van Baarle, L., Matteoli, G., & Verbeke, K. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000036 · Cited by 11
Immunoregulatory Functions of Nuclear Receptors: Mechanisms and Therapeutic Implications
Zhao, L., Gimple, R. C., Yang, Z., Wei, Y., Gustafsson, J.-Α., & Zhou, S. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.10.002 · Cited by 9
Zhu, J., Shentu, C., Meng, Q., Fan, S., Tang, Y., Mao, M., & Yuan, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1585748 · Cited by 8
Microbial transformation of secondary bile acids: roles in gut ecology and autoimmune diseases
Ren, L., Li, M., Wu, L., Lin, Z. M., & Chen, A. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1769792 · Cited by 10
Restoring FXR expression as a novel treatment strategy in liver cancer and other liver disorders
Girisa, S., Aswani, B. S., Manickasamy, M. K., Hegde, M., Alqahtani, M. S., Abbas, M., Sethi, G., & Kunnumakkara, A. B. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2487465 · Cited by 8
Li, C., Wang, H., He, R.-J., Huang, J., Song, L.-L., Song, Y., Huo, P.-C., Hou, J., Ji, G., & Ge, G. (2022) · Food & Function · doi:10.1039/d1fo03277a · Cited by 9
Datta, A., Hernandez-Franco, J. F., Park, S., Olson, M. R., HogenEsch, H., & Thangamani, S. (2022) · Journal of Fungi · doi:10.3390/jof8060610 · Cited by 9
Xu, Z., Huang, G., Gong, W., Zhao, Y., Zhou, P., Zeng, Y., & He, F. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0008 · Cited by 8
The interaction between HCV and nuclear receptor-mediated pathways
Raglow, Z., Thoma-Perry, C., Gilroy, R. K., & Wan, Y. Y. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.005 · Cited by 9
Advances of exosome regulating‑FXR to repair inflammatory bowel disease (Review)
Muro, P., Jing, C., Qiao, Y., Wang, W., Wang, B., & Mao, F. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5576 · Cited by 7
FXR in bone metabolism: An emerging regulator
Rizvi, S. M. M. H., Aihemaiti, S., Kan, Y., Tao, S., & Liu, H. (2026) · iScience · doi:10.1016/j.isci.2026.114842 · Cited by 11
Pleiotropic immunoregulation by bile acids in pathophysiology
Lin, B.-S., Yin, M., Xie, S.-A., Li, P., & Li, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1719092 · Cited by 11
Zhan, M., Zhao, C., Han, Y., Chen, B., Chen, Y., Song, M., Cao, Y., & Xiao, H. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c16340 · Cited by 7
Aljabban, J., Rohr, M., Borkowski, V. J., Nemer, M., Cohen, E., Hashi, N. J., Aljabban, H., Boateng, E., Syed, S. A., Mohammed, M., et al. (2022) · Journal of Pathology Informatics · doi:10.1016/j.jpi.2022.100094 · Cited by 9
Impact of intestinal microenvironments in obesity and bariatric surgery on shaping macrophages
Leyderman, M., Wilmore, J. R., Shope, T. R., Cooney, R. N., & Urao, N. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000033 · Cited by 9
Veetil, N. K., Henschen, A. E., Hawley, D. M., Melepat, B., Dalloul, R. A., Beneš, V., Adelman, J. S., & Vinkler, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1250818 · Cited by 7
Effects of gut bacteria and their metabolites on gut health of animals
Hao, Z., Ding, X., & Wang, J. (2024) · Advances in applied microbiology · doi:10.1016/bs.aambs.2024.02.007 · Cited by 7
Neuronal Activation of the Gastrointestinal Tract Shapes the Gut Environment in Mice
Yoo, B. B., Griffiths, J. A., Thuy-Boun, P. S., Cantu, V., Weldon, K. C., Challis, C., Sweredoski, M. J., Chan, K. Y., Thron, T., Sharon, G., et al. (2021) · CaltechAUTHORS (California Institute of Technology) · Cited by 8
Response Variability to Drug Testing in Two Models of Chemically Induced Colitis
Suau, R., Garcia, A., Bernal, C., Llaves, M., Schiering, K., Jou-Ollé, E., Pertegaz, A., García-Jaraquemada, A., Bartolí, R., Lorén, V., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076424 · Cited by 8
Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in MAFLD and COVID-19 OutcomesPreprint
Buchynskyi, M., Oksenych, V., Kamyshna, I. I., Vorobets, I., & Kamyshnyi, O. (2024) · Preprints.org · doi:10.20944/preprints202405.0815.v1 · Cited by 7
Kaur, S., & Thakur, R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11195-7 · Cited by 10
Olejnik, P., Buczma, K., Cudnoch‐Jędrzejewska, A., & Kasarełło, K. (2024) · Immunologic Research · doi:10.1007/s12026-024-09471-y · Cited by 9
Wang, Y., Bendre, S. V., Krauklis, S. A., Steelman, A. J., & Nelson, E. R. (2025) · Endocrinology · doi:10.1210/endocr/bqaf031 · Cited by 6
Wang, R., Feng, B., Yao, Q., Pan, Q., Yu, J., Liu, C., Wang, J., Li, L., Cao, H., & Xie, J. (2025) · Communications Biology · doi:10.1038/s42003-025-08261-y · Cited by 8
Liver fibrosis pathologies and potentials of RNA based therapeutics modalities
Diwan, R., Gaytan, S. L., Bhatt, H. N., Pena‐Zacarias, J., & Nurunnabi, M. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01551-8 · Cited by 8
Bile Acids as Signaling Molecules
Claudel, T., & Trauner, M. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch25 · Cited by 9
Cipriani, S., Mencarelli, A., Chini, M. G., Distrutti, E., Renga, B., Bifulco, G., Baldelli, F., Donini, A., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/annotation/55febddb-0209-4a48-9c14-23df882126a2 · Cited by 8
Self-citationBile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance
Chen, Q., Xin, L. I. U., & Jiang, Z.-H. (2026) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2026.01.001 · Cited by 6
Huang, W., Qian, Y., Lin, J., Wang, F., Kong, X., & Tan, W. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149670 · Cited by 6
Metadata
- Authors
- Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S.
- Affiliations
- University of Perugia (IT)
- Azienda Ospedaliera di Perugia (IT)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-11
- Volume
- 183
- Issue
- 10
- Pages
- 6251-6261
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125524268
- Cited by
- 655
- References
- 34
- Citations by year
- 2026: 42 · 2025: 51 · 2024: 49 · 2023: 52 · 2022: 71 · 2021: 56 · 2020: 55 · 2019: 40 · 2018: 34 · 2017: 36 · 2016: 31 · 2015: 31 · 2014: 25 · 2013: 22 · 2012: 25
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- farnesoid X receptor, intestinal innate immunity, colitis, Crohn's disease, NF-κB, SHP, NCoR, macrophages, chenodeoxycholic acid, trinitrobenzene sulfonic acid, dextran sulfate, TNF-α, IL-1β, interleukin-6, intestinal inflammation, nuclear receptors, intestinal homeostasis
- MeSH terms
- Receptor, Farnesoid X-Activated, Acute Disease, Adult, Animals, Chronic Disease, Colitis, Crohn Disease, Female, Humans, Immunity, Innate, Intestinal Mucosa, Intestines, Lipopolysaccharides, Macrophages, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Trinitrobenzenesulfonic Acid, NF-kappa B, Mice, SCID, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.